SMI-Ribosome inactivating protein conjugates selectively inhibit tumor cell growth

被引:9
|
作者
Roy, Saumya [1 ]
Axup, Jun Y. [1 ]
Forsyth, Jane S. [2 ]
Goswami, Rajib K. [1 ,3 ]
Hutchins, Benjamin M. [1 ]
Bajuri, Krishna M. [1 ]
Kazane, Stephanie A. [1 ,4 ]
Smider, Vaughn V. [1 ]
Felding, Brunhilde H. [2 ]
Sinha, Subhash C. [1 ,5 ]
机构
[1] Scripps Res Inst, Dept Cell & Mol Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Chem Physiol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA
[3] Indian Assoc Cultivat Sci, Dept Organ Chem, Kolkata, India
[4] Pfizer Inc, Ctr Therapeut Innovat, 10770 Sci Ctr Dr, San Diego, CA 92121 USA
[5] Rockefeller Univ, Lab Mol & Cellular Neurosci, 1230 York Ave, New York, NY 10065 USA
关键词
INTEGRIN; IMMUNOTOXINS; EXPRESSION;
D O I
10.1039/c7cc00745k
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Cell-targeting conjugates of Saporin 6, a ribosome inactivating protein (RIP), were prepared using the Saporin Ala 157 Cys mutant, a small molecule inhibitor (SMI) of integrins alpha(v)beta(3)/alpha(v)beta(5), and a potent cytotoxin, auristatin F (AF). The conjugates selectively and potently inhibited proliferation of tumor cells expressing the target integrins. We anticipate that the small molecule-RIP bioconjugate approach can be broadly applied using other small molecule drugs.
引用
收藏
页码:4234 / 4237
页数:4
相关论文
共 50 条
  • [31] A proapoptotic peptide conjugated to penetratin selectively inhibits tumor cell growth
    Alves, Isabel D.
    Carre, Manon
    Montero, Marie-Pierre
    Castano, Sabine
    Lecomte, Sophie
    Marquant, Rodrigue
    Lecorche, Pascaline
    Burlina, Fabienne
    Schatz, Christophe
    Sagan, Sandrine
    Chassaing, Gerard
    Braguer, Diane
    Lavielle, Solange
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2014, 1838 (08): : 2087 - 2098
  • [32] A CONJUGATE BETWEEN HUMAN UROKINASE AND SAPORIN, A TYPE-1 RIBOSOME-INACTIVATING PROTEIN, IS SELECTIVELY CYTOTOXIC TO UROKINASE RECEPTOR-EXPRESSING CELLS
    CAVALLARO, U
    DELVECCHIO, A
    LAPPI, DA
    SORIA, MR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (31) : 23186 - 23190
  • [33] A novel mitochondriotoxic small molecule that selectively inhibits tumor cell growth
    Fantin, VR
    Berardi, MJ
    Scorrano, L
    Korsmeyer, SJ
    Leder, P
    CANCER CELL, 2002, 2 (01) : 29 - 42
  • [34] Physiological concentrations of transforming growth factor β1 selectively inhibit human dendritic cell function
    Fogel-Petrovic, MiIjana
    Long, Julie A.
    Misso, Neil L.
    Foster, Paul S.
    Bhoola, Kanti D.
    Thompson, Philip J.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2007, 7 (14) : 1924 - 1933
  • [35] Novel benzimidazole derivatives selectively inhibit endothelial cell growth and suppress angiogenesis in vitro and in vivo
    Hori, A
    Imaeda, Y
    Kubo, K
    Kusaka, M
    CANCER LETTERS, 2002, 183 (01) : 53 - 60
  • [36] A recombinant cell-permeable p53 fusion protein is selectively stabilized under hypoxia and inhibits tumor cell growth
    Zhao, Yu
    Wu, Junhua
    Wu, Shaoping
    Jia, Peiyuan
    Tong, Ying
    Wu, Xumin
    Wang, Yuxia
    CANCER LETTERS, 2009, 279 (01) : 101 - 107
  • [37] TARGETING GLIOBLASTOMA MITOCHONDRIAL METABOLISM TO INHIBIT CELL PROLIFERATION & TUMOR GROWTH
    Jue, T. J.
    Chung, S. A.
    Rapkins, R. W.
    Dilda, P.
    Hogg, P.
    McDonald, K. L.
    NEURO-ONCOLOGY, 2017, 19 : 59 - 59
  • [38] KINETIC-STUDY OF THE CYTOTOXIC EFFECT OF ALPHA-SARCIN, A RIBOSOME-INACTIVATING PROTEIN FROM ASPERGILLUS-GIGANTEUS, ON TUMOR-CELL LINES - PROTEIN-BIOSYNTHESIS INHIBITION AND CELL-BINDING
    TURNAY, J
    OLMO, N
    JIMENEZ, A
    LIZARBE, MA
    GAVILANES, JG
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 1993, 122 (01) : 39 - 47
  • [39] NORMAL HUMAN MONOCYTES INHIBIT TUMOR-CELL GROWTH INVITRO
    KING, GW
    FILE, J
    LOBUGLIO, AF
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1978, 62 (05) : 283 - 288
  • [40] Neural progenitor cell lines inhibit rat tumor growth in vivo
    Staflin, K
    Honeth, G
    Kalliomäki, S
    Kjellman, C
    Edvardsen, K
    Lindvall, M
    CANCER RESEARCH, 2004, 64 (15) : 5347 - 5354